Dyne Therapeutics Inc Sustainability Reports
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company focused on advancing innovative life-transforming therapeutics for patients with genetically driven muscle diseases. The company utilizes its proprietary FORCE platform to develop modern oligonucleotide therapeutics that optimize tissue penetration and delivery to muscle tissue.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00NSGPJF8
5 reports from 2020 to 2025
Company Profile
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company focused on advancing innovative life-transforming therapeutics for patients with genetically driven muscle diseases. The company utilizes its proprietary FORCE platform to develop modern oligonucleotide therapeutics that optimize tissue penetration and delivery to muscle tissue.
Reports
5 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
